Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
基本信息
- 批准号:10390489
- 负责人:
- 金额:$ 48.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAcidsAcute PainAddressAdenosineAdenosine A1 ReceptorAffectAfferent NeuronsAgonistAnalgesicsAnimalsAppearanceAttenuatedBehaviorBiocompatible MaterialsBone InjuryBone callusBrain-Derived Neurotrophic FactorBuprenorphineCaringClinicalCyclic AMPDataDependenceDevelopmentDinoprostoneDoseEconomic BurdenEnvironmentEsthesiaFacial ExpressionFractureGoalsHarvestHyaluronic AcidIn VitroInjectableInjuryIon ChannelLightLocomotionMatrix MetalloproteinasesMechanicsMediatingMedicalMembrane PotentialsMicrofluidic MicrochipsMicrofluidicsMusNerveNeuraxisNeuronsNeuropeptidesNociceptorsNon-Steroidal Anti-Inflammatory AgentsOpioidOrthopedic SurgeryOrthopedicsOsteogenesisPainPain managementPeripheralPeripheral NervesPharmaceutical PreparationsPrevalenceProductionPurinergic P1 ReceptorsRNA analysisReceptor SignalingRegulationRoleSensory ReceptorsSeriesSignal TransductionSiteSmall Interfering RNAStainsStimulusTRPV1 geneTestingTherapeuticTherapeutic AgentsTibial FracturesTissuesTraumaWeight-Bearing stateWorkaddiction liabilityantagonistbasebehavior testbone fracture repairchronic painconditional knockoutcrosslinkexperimental studyextracellulargait examinationhealingimprovedin vivoknock-downneurite growthneurotrophic factornovel therapeutic interventionnovel therapeuticspain reductionpain reliefpain sensitivityreceptorreceptor expressionscaffoldside effectskeletalskeletal tissuesmall moleculesuccesstherapeutically effectivetibiatranscriptome sequencingtranscriptomics
项目摘要
ABSTRACT
Management of pain arising from orthopedic fractures remains a challenge as common analgesic medications
such as non-steroidal anti-inflammatory drugs (NSAIDs) and opiates either interfere with healing or possess
unwanted side effects such as dependence. Given the prevalence of pain associated with orthopedic surgeries
and bone fractures, there is an urgent need to develop therapeutic strategies that can mitigate pain while
promoting fracture healing. This motivated us to study the potential use of adenosine (ADO) as a therapeutic
agent for managing fracture pain. ADO is a naturally occurring small molecule that is released upon injury and
elicits analgesic effects in peripheral and central nerves. We and others have shown that extracellular ADO is
an effective osteoanabolic agent promoting bone formation and fracture healing. The osteoanabolic function of
ADO along with the analgesic function makes it an ideal molecule to treat fracture pain. The overarching goal of
the proposal is to assess the use of ADO for the management of pain in fracture injuries by advancing the
fundamental understanding of how ADO mitigates fracture pain and developing new clinically viable therapeutic
strategies. Towards this, Aim 1 of the proposal will develop and characterize an injectable biomaterial for local
delivery of ADO to the fracture site, and determine the dose-dependent effect on fracture healing. To determine
whether biomaterial-assisted local delivery of ADO provides analgesic effects following fracture injury, studies in
Aim 2 will perform behavioral tests for pain, tissue analyses, in vitro analyses by developing DRG-on-Chip
platforms, and RNA sequencing. Aim 3 will test the hypothesis that ADO-mediated fracture pain mitigation
involves A1 receptors (A1Rs) by using animals with conditional knockout of A1R in sensory neurons, and
elucidates its regulation of ion channels. Completion of this proposal will establish a new therapeutic molecule
for the care of fracture trauma, and potentially change how bone injuries are treated. The broad impact of our
studies using localized delivery of ADO could be extended to the management of various types of acute and
chronic pain that originate in the peripheral or central nervous system.
抽象的
骨科骨折引起的疼痛的管理仍然是一个挑战,因为常见的镇痛药
例如非甾体类抗炎药(NSAID),阿片类药物要么干扰或拥有
不必要的副作用,例如依赖性。鉴于与骨科手术有关的疼痛患病率
和骨折,迫切需要制定可以减轻疼痛的治疗策略
促进断裂愈合。这促使我们研究了腺苷(ADO)作为治疗的潜在用途
管理骨折疼痛的代理。 ADO是一种天然存在的小分子,在受伤后释放
引起周围和中央神经的镇痛作用。我们和其他人已经表明细胞外ADO是
一种有效的骨代谢剂,促进骨形成和断裂愈合。骨拨函数的功能
ADO以及镇痛功能使其成为治疗断裂疼痛的理想分子。总体目标
该提议是通过推进骨折伤害的疼痛的使用来评估ADO的使用
基本了解ADO如何减轻骨折疼痛并发展新的临床可行治疗
策略。为此,提案的目标1将发展并表征当地的注射生物材料
将ADO递送到断裂部位,并确定剂量依赖性对断裂愈合的作用。确定
生物材料辅助ADO的局部递送是否在骨折损伤后会产生镇痛作用,研究
AIM 2将通过开发芯片DRG进行疼痛,组织分析,组织分析的行为测试
平台和RNA测序。 AIM 3将检验Ado介导的减轻骨折疼痛的假设
通过在感觉神经元中使用动物与A1R有条件敲除的动物,涉及A1受体(A1RS),并且
阐明其对离子通道的调节。该建议的完成将建立一个新的治疗分子
为了护理骨折创伤,并有可能改变治疗骨损伤的方式。我们的广泛影响
使用ADO局部交付的研究可以扩展到各种急性的管理
起源于周围或中枢神经系统的慢性疼痛。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shyni Varghese其他文献
Shyni Varghese的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shyni Varghese', 18)}}的其他基金
Molecular engineering of HA-based lubricants for articular cartilage
用于关节软骨的 HA 基润滑剂的分子工程
- 批准号:
10712721 - 财政年份:2023
- 资助金额:
$ 48.06万 - 项目类别:
Localization of adenosine to promote fracture healing
腺苷定位促进骨折愈合
- 批准号:
10461465 - 财政年份:2022
- 资助金额:
$ 48.06万 - 项目类别:
Localization of adenosine to promote fracture healing
腺苷定位促进骨折愈合
- 批准号:
10700832 - 财政年份:2022
- 资助金额:
$ 48.06万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10543700 - 财政年份:2021
- 资助金额:
$ 48.06万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10614931 - 财政年份:2021
- 资助金额:
$ 48.06万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10227375 - 财政年份:2021
- 资助金额:
$ 48.06万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10812649 - 财政年份:2021
- 资助金额:
$ 48.06万 - 项目类别:
Bioinspired Synthetic Grafts for Bone Regeneration
用于骨再生的仿生合成移植物
- 批准号:
9551215 - 财政年份:2017
- 资助金额:
$ 48.06万 - 项目类别:
Adenosine A2B Receptor in Bone Health and Osteoporosis
腺苷 A2B 受体在骨骼健康和骨质疏松症中的作用
- 批准号:
9551206 - 财政年份:2017
- 资助金额:
$ 48.06万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
深层碳酸盐岩酸蚀裂缝中反应-非线性两相流界面演化机制研究
- 批准号:52304047
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
核苷酸代谢酶氧化修饰调控上皮干细胞命运在口腔白斑病光动力治疗复发中的机制与意义研究
- 批准号:82330029
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
RNF31通过厚壁菌代谢产物3-氧代胆碱酸调控RORγ信号轴抑制Th17细胞分化—溃疡性结肠炎干预新靶点
- 批准号:82360112
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氨基酸转运体调控非酒精性脂肪肝的模型建立及机制研究
- 批准号:32371222
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Cell-directed gene therapy for pain recovery after surgery and inflammation
用于手术和炎症后疼痛恢复的细胞定向基因疗法
- 批准号:
10546458 - 财政年份:2022
- 资助金额:
$ 48.06万 - 项目类别:
Cell-directed gene therapy for pain recovery after surgery and inflammation
用于手术和炎症后疼痛恢复的细胞定向基因疗法
- 批准号:
10390750 - 财政年份:2022
- 资助金额:
$ 48.06万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10543700 - 财政年份:2021
- 资助金额:
$ 48.06万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10614931 - 财政年份:2021
- 资助金额:
$ 48.06万 - 项目类别:
Modulation of local adenosine signaling to attenuate fracture pain
调节局部腺苷信号传导以减轻骨折疼痛
- 批准号:
10227375 - 财政年份:2021
- 资助金额:
$ 48.06万 - 项目类别: